atenolol has been researched along with metipranolol in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bard, B; Carrupt, PA; Martel, S | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Jancinová, V; Nosál, R; Petríková, M | 1 |
Jancinová, V; Nosál, R | 1 |
Baumgart, P; Fehske, KJ; Häcker, W; Karoff, C; Losse, H; Vetter, H; Zidek, W | 1 |
Balgavý, P; Jakubovský, J; Jancinová, V; Nosál, R; Ondrias, K | 1 |
1 trial(s) available for atenolol and metipranolol
Article | Year |
---|---|
Intracellular sodium and calcium during antihypertensive treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Body Fluids; Calcium; Erythrocytes; Humans; Hypertension; Intracellular Fluid; Metipranolol; Middle Aged; Pindolol; Sodium; Sulfonamides | 1985 |
6 other study(ies) available for atenolol and metipranolol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arachidonic Acid; Atenolol; Blood Platelets; Male; Membrane Fluidity; Metipranolol; Oxprenolol; Platelet Aggregation Inhibitors; Practolol; Propranolol; Rats; Rats, Wistar; Thrombin; Thromboxane A2 | 1992 |
Differences among beta-adrenoceptor blocking drugs in modifying platelet aggregation and arachidonic acid liberation under thrombin stimulation.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arachidonic Acid; Arachidonic Acids; Atenolol; Hydrolysis; Metipranolol; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Platelet Aggregation Inhibitors; Propranolol; Solubility; Thrombin | 1989 |
The interaction of beta-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membrane.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Calcium; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Male; Mathematics; Membrane Fluidity; Metipranolol; Microscopy, Electron; Platelet Aggregation; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Temperature | 1985 |